.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Federal Trade Commission
Cipla
Harvard Business School
Fish and Richardson
Deloitte
Mallinckrodt
Novartis
US Department of Justice

Generated: December 14, 2017

DrugPatentWatch Database Preview

Methyl aminolevulinate hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for methyl aminolevulinate hydrochloride and what is the scope of methyl aminolevulinate hydrochloride patent protection?

Methyl aminolevulinate hydrochloride
is the generic ingredient in one branded drug marketed by Galderma Labs Lp and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are four hundred and seventy-nine drug master file entries for methyl aminolevulinate hydrochloride.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Galderma Labs LpMETVIXIAmethyl aminolevulinate hydrochlorideCREAM;TOPICAL021415-001Jul 27, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: methyl aminolevulinate hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Galderma Labs LpMETVIXIAmethyl aminolevulinate hydrochlorideCREAM;TOPICAL021415-001Jul 27, 2004► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Merck
Accenture
Chubb
Baxter
QuintilesIMS
Cantor Fitzgerald
Cerilliant
Citi
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot